090435:KRXAmorepacific Corporation Analysis
Data as of 2026-03-07 - not real-time
₩47,050.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Amorepacific trades at roughly 47,050 KRW, essentially matching its DCF‑derived fair value of about 47,011 KRW, suggesting a *fairly valued* position. The stock sits just above its 200‑day SMA (≈42,260 KRW) but below the 50‑day SMA (≈48,119 KRW), while the 20‑day SMA (≈51,680 KRW) remains higher, indicating mixed short‑term momentum. Technical signals are mixed: RSI is around 42 (neutral‑to‑slightly bearish), MACD is in a bearish crossover, and volume is trending down, all of which temper upside expectations in the near term.
Fundamentally, the company delivers strong gross margins (~72%) and a solid dividend yield (2.65%) with a payout ratio under 50%, backed by ample cash (≈872 B KRW) that more than covers its debt. Revenue is growing modestly (~4% YoY) but profitability metrics (operating margin ~9%, profit margin ~3.8%) and ROE (~3.3%) are low, reflecting a *blend* of growth and value characteristics.
Fundamentally, the company delivers strong gross margins (~72%) and a solid dividend yield (2.65%) with a payout ratio under 50%, backed by ample cash (≈872 B KRW) that more than covers its debt. Revenue is growing modestly (~4% YoY) but profitability metrics (operating margin ~9%, profit margin ~3.8%) and ROE (~3.3%) are low, reflecting a *blend* of growth and value characteristics.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD crossover
- Decreasing volume trend
- Valuation already aligned with DCF
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Stable dividend yield with sustainable payout
- Strong cash position offsetting high debt ratio
- Defensive consumer sector supporting steady demand
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consistently high gross margins and brand strength
- Long‑term dividend attractiveness
- Resilience of consumer‑defensive segment
Key Metrics & Analysis
Financial Health
Revenue Growth4.10%
Profit Margin3.78%
ROE3.31%
ROA3.36%
Debt/Equity6.25
Op. Cash Flow₩530.6B
Free Cash Flow₩472.6B
Technical Analysis
TrendBullish
RSI42.1
Support₩42,500.00
Resistance₩56,700.00
MA 20₩51,680.00
MA 50₩48,119.00
MA 200₩44,260.25
MACDBearish
VolumeDecreasing
Fear & Greed Index68.77
Valuation
Fair Value₩47,011.52
Target Price₩0.00
GradeFair
TypeBlend
Dividend Yield2.65%
Risk Assessment
Beta0.26
Volatility64.84%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.